Edoxaban improves acute venous thromboembolism while preserving protein C and protein S levels

Journal of cardiology
Hiromu YamazakiMasataka Sata

Abstract

It is well known that warfarin inhibits the synthesis of vitamin K-dependent anticoagulants, including thrombin, protein C and S, and factor Xa, leading, paradoxically, to an initial hypercoagulable state. Edoxaban, a direct inhibitor of activated factor X is widely used for the treatment of acute venous thromboembolism (VTE). However, the effect of edoxaban on circulating coagulation factors, in patients with acute VTE, remains unknown. We enrolled 57 patients with acute VTE with/without pulmonary embolism treated with edoxaban (n=37) or warfarin (n=20) in a clinical setting. Before treatment and 2 weeks after treatment, we evaluated thrombotic burden using ultrasound or computed tomography angiography. We also evaluated thrombin generation, represented by prothrombin fragment F1+2; thrombus degradation, represented by D-dimer; and levels of anticoagulants, including protein C, protein S, and antithrombin III. Both edoxaban and warfarin treatment improved thrombotic burden and decreased prothrombin fragment F1+2, and D-dimer. Edoxaban treatment preserved protein C and protein S levels. In contrast, warfarin decreased protein C and protein S levels. Neither treatment affected antithrombin III. Edoxaban improves VTE while preser...Continue Reading

Citations

May 9, 2019·The Journal of Medical Investigation : JMI·Shusuke YagiMasataka Sata
Feb 1, 2021·Neurology and Therapy·Saba NaghaviIman Adibi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Hideo WadaYoshiki Yamashita
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Dean M Robinson, Keri Wellington
© 2022 Meta ULC. All rights reserved